Terms: = Pancreatic cancer AND NCOA2, TIF2, 10499, ENSG00000140396, NCoA-2, MGC138808 AND Treatment
1 results:
1. Identification of formononetin as the active compound of CR-SR in hepatocellular carcinoma treatment: An integrated approach combining network pharmacology and weighted gene co-expression networks.
Li C; Xie Y; Hu S; Yu H; Xu Y; Shen H; Yuan Y; Gu L; Pu B
Chem Biol Drug Des; 2024 Jan; 103(1):e14363. PubMed ID: 37793997
[TBL] [Abstract] [Full Text] [Related]
